Search Results for: COMBINATION CORNER How to Approach

Articles

July 12, 2012

7/18/2012 July 12, 2012

Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc....

May 14, 2012

5/16/2012 May 14, 2012

Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...

September 25, 2011

9/27/2011 September 25, 2011

Thermo Fisher Scientific Introduces New Imaging ATR Accessory Thermo Fisher Scientific Inc., a world leader in serving science, recently announced...

July 16, 2026

Why NAMs Took Decades to Arrive – and Why iPSCs are Making Them Possible

When US and European regulators acted in recent years to support the use of animal model alternatives for drug development, reactions were mixed. There is broad acknowledgement regarding the limitations of animal-based disease models and their inability to fully recapitulate human biological complexity, contributing to a high clinical failure rate, and so there was true excitement for the possibilities.